ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 108 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,778,365 | +83142.2% | 1,141,500 | +1.6% | 0.01% | -14.3% |
| Q1 2024 | $4,539 | -0.5% | 1,123,400 | -24.9% | 0.01% | 0.0% |
| Q4 2023 | $4,564 | +12.3% | 1,496,303 | +10.5% | 0.01% | 0.0% |
| Q3 2023 | $4,064 | -20.3% | 1,354,541 | -0.6% | 0.01% | 0.0% |
| Q2 2023 | $5,099 | +109.1% | 1,363,382 | +87.4% | 0.01% | +133.3% |
| Q1 2023 | $2,438 | -18.3% | 727,700 | +17.3% | 0.00% | -25.0% |
| Q4 2022 | $2,985 | -99.9% | 620,600 | +3.9% | 0.00% | -20.0% |
| Q3 2022 | $3,399,000 | -27.8% | 597,400 | -9.9% | 0.01% | -16.7% |
| Q2 2022 | $4,707,000 | -44.0% | 663,000 | -43.1% | 0.01% | -40.0% |
| Q1 2022 | $8,411,000 | +51.5% | 1,165,000 | +87.7% | 0.01% | +42.9% |
| Q4 2021 | $5,550,000 | +600.8% | 620,800 | +2646.9% | 0.01% | +600.0% |
| Q3 2021 | $792,000 | – | 22,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 5,462,079 | $16,659,341 | 12.62% |
| TANG CAPITAL MANAGEMENT LLC | 4,076,741 | $12,434,060 | 1.15% |
| Stonepine Capital Management, LLC | 839,514 | $2,560,518 | 1.11% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,581,196 | 0.73% |
| CM Management, LLC | 270,000 | $823,500 | 0.66% |
| EcoR1 Capital, LLC | 6,995,861 | $21,337,376 | 0.55% |
| Acuitas Investments, LLC | 171,098 | $615,373 | 0.32% |
| Newtyn Management, LLC | 508,474 | $1,550,846 | 0.30% |
| Diametric Capital, LP | 161,524 | $492,648 | 0.30% |
| Auour Investments LLC | 177,000 | $670,830 | 0.26% |